There are some interesting new stuff, like NGF drops, but only a few people have tested them and results are not shown in the survey. We just don’t have enough user experiences and existing ones are more anecdotic. http://www.longecity.org/forum/topic/72272-ngf-spray/
Also we now have very large and easily available base of knowledge and vendors for any nootropic, which make search and personal testing much easy, and provide better personal results with existing nootropics. Combining, cycling and personal targeting of nootropics provide much better personal results from my experiences.
There are several promising compounds in testing phase, like different AMPAkines.
Also I think that there were some sampling problems with the survey as it puts racetams so low.
There are several promising compounds in testing phase, like different AMPAkines.
Ah yes. The Ampakines are the nootropics of the future—and always will be. I’ve been hearing since what must be the early ’00s about how amazing the ampakines are. But aside from the -racetams...
I think that there is several answers:
There are some interesting new stuff, like NGF drops, but only a few people have tested them and results are not shown in the survey. We just don’t have enough user experiences and existing ones are more anecdotic. http://www.longecity.org/forum/topic/72272-ngf-spray/
Also we now have very large and easily available base of knowledge and vendors for any nootropic, which make search and personal testing much easy, and provide better personal results with existing nootropics. Combining, cycling and personal targeting of nootropics provide much better personal results from my experiences.
There are several promising compounds in testing phase, like different AMPAkines.
Also I think that there were some sampling problems with the survey as it puts racetams so low.
Ah yes. The Ampakines are the nootropics of the future—and always will be. I’ve been hearing since what must be the early ’00s about how amazing the ampakines are. But aside from the -racetams...